Acute renal failure
Definition
=ARF :
rapid decrease the renal function or urine output ↑Cr>0.5mg/dl, or ↑Cr>50%, or ↓GFR>50%
=Oliguria : (urine output < 500 mL/d)
-is a frequent
-but not invariable clinical feature
(-50%).
=Anuria : urine output<100cc/day
=For purposes of diagnosis and management,
ARF are divided into three categories:
(1) Prerenal ARF, prerenal azotemia(-55%)
diseases/that cause renal hypoperfusion
without compromising integrity of renal parenchyma
(2) intrinsic renal ARF, renal azotemia (-40%)
diseases that directly involve renal parenchyma
(3) postrenal ARF, postrenal azotemia (-5%).
diseases associated with urinary tract obstruction
=History and physical :special attention to recent
procedures and medications, vital signs, volume status, sign of CHF, signs and symptoms of obstruction, vascular disease or systemic disease
=Serum electrolyte, Na, BUN, Cr, Hb/Ht, uric acid,
=Urine evaluation: Na, Cr, osmolality, I/O, urinalysis, sediment, electrolytes and osmolality, fractional excretion of Na (FeNa) =(UNa/PNa)/(UCr/PCr)
(need simultaneous serum electrolytes)
Pre-renal and oliguric ATN RF
診斷 |
|
U/P Cr |
|
UNa |
|
FENa (%) |
Uosmolality |
|
|
|
|
|
|
|
|
Pre-renal RF |
|
>40 |
|
<20 |
|
<1 |
>500 |
|
|
|
|
|
|
|
|
Intrinsic RF |
|
<20 |
|
>40 |
|
>1 |
<350 |
=Renal ultrasonography
useful to r/o obstruction and evaluate
kidney size to estimate chronicity of RF
Category |
Etiology |
Pre-renal (↓renal blood flow) |
↓cardiac output, ↓effective artery volume, sepsis, Hypovolemia, cirrhosis (hepato-renal syndrome) Drug : ACEi, NSAID, Contrast dye, cyclosporine |
Renal |
Acute tubular necrosis (ATN) -Ischemia: progression of any prerenal process toxins -Drug: aminoglycocydes, amphoterecin, Cisplatin, contrast dye -Pigmets: (myoglobin, Hb), Crystal (Uric acid) or Proteins (IgG light chains) Acute interstitial nephritis (AIN) -Allergic: β-lactamantibiotics, sulfa drugs, NSAIDs, -Infection -Infiltration (sarcoid, lymphoma) -Auto immune (SLE) -Vascular : renal artery stenoses(especially bilateral +ACEi) thrombosis, hypertensive crisis, sclerderma renal crisis Cholesterol emboli, HUS/TTP Acute glomerulonephritis (AGN) |
Post-renal (Obstruction of urine) |
Bladder neck: BPH, prostate cancer, neuropathy, anticholindergic medication Ureteral : Malignancy, Lymphadenopathy, retroperitoneal fibrosis Tubular : precipitation of crystals |
=Renal biopsy: consider if suspect AGN
[rapid ↑in Cr, proteinuria (sometimes in the
nephrotic range), and an active urinary
sediment with hematuria and RBC casts.]
DD of Postrenal ARF
- Bladder catheterization
assessment of Lower tract obstruction
- Ultrasonography usually identifies
lower and upper tract obstruction
-IVP
-CT
Complications
- Volume overload( edema, congestive HF)
- hyperkalemia, hyperphosphatemia
- Uremia (encephalopathy, pericarditis,
nausea, vomiting)
Prevention and treatment of ARF
Management of ARF
Prerenal azotemia
I. Hemodynamic monitoring
-adequate volume expansion while
avoiding overexpansion
- assess and manage poor
cardiac function
-Invasive monitoring with a
central venous pressure or
pulmonary artery catheter
II. Fluid Challenge
-The quantity must be determined on an individual
basis, but typically 500-1000 ml normal saline is
infused over 30-60 minutes.
-If no response is obtained, volume infusion can
be followed by furosemide, 100-400 mg iv to
promote urine flow.
-Metolazone, 5-10 mg PO
-Furosemide 10mg-40mg/H continue drip
Management of Radiocontrast nephropathy:
=Risk factor of Radiocontrast nephropathy
(1)long term DM
(2)Pre-existing renal insufficiency (Cr>1.5)
(3)volume depletion
(4)multiple myeloma
(5)CHF
(6)>65y/o
=tends to be oliguric,
-serum Cr peaks in the first 72 hours.
-Hydration
-12-24 hours before contrast and
ending 12 hours after the contrast study.
-Infusion rates need to be individualized
-75-150 ml/hour of 0.45% saline, the
-goal being a slightly volume-expanded patient
with a high urine output.
-Acetylcystine
-1.5g/day (2pk qid/day)
- starting 1 day before procedure until 12hours
after procedure
III. Obstructive nephropathy in the upper or lower urinary tract may incite ARF
=Relief of obstruction
-Foley
-Surgery process
- If the post-obstructive diuresis appears excessive,
fluid and electrolytes should be replaced.
-The appropriate initial replacement fluid in such
cases is usually 0.45% saline.
Prevention and treatment of complications
=Intravascular volume overload
-Salt (1-2 g/d) and water restriction
(usually 1-1.5 L/d)
-Diuretics (usually loop blockers ± thiazide)
(lasix max dose=1g/day)
-Ultrafiltration or dialysis
Prevention and treatment of complications
=Hyponatremia
-Restriction of enteral free water intake
(<1 L/d)
-Avoid hypotonic intravenous solutions
(including dextrose solutions)
=Hyperkalemia -Restriction of dietary K intake
(usually <40 mmol/d)
-Eliminate K* supplements and
K-sparing diuretic
-Potassium-binding ion-exchange resins
(e.g., Kyxalate)
-Glucose (50 mL of 50 dextrose)
and insulin (10 units regular)
-Sodium bicarbonate
(usually 50-100 mmol)
-Calcium gluconate
(10 mL of 10 solution over 5 min)
-Dialysis (with low K* dialysate)
=Metabolic acidosis -Restriction of dietary protein
(usually 0.6 g/kg per day of
high biologic value)
-Sodium bicarbonate
(maintain serum bicarbonate
>15 mmol/L or arterial pH >7.15)
-Dialysis
=Nutrition
-Restriction of dietary protein (0.6 g/kgper day)
-Carbohydrate (100 g/d)
-Enteral or parenteral nutrition
(if recovery prolonged or pt very catabolic)
=Indications for dialysis
-Clinical evidence (symptoms or signs) of uremia
-Intractable intravascular volume overload
-Hyperkalemia or severe acidosis
resistant to conservative measures
-Prophylactic dialysis when
urea >100-150 mg/dL or
creatinine >8-10 mg/dL
Fluid control for CRRT
PAWP |
<6 mmHg |
6-8 mmHg |
9-11 mmHg |
12-14 mmHg |
15-17 mmHg |
18-20 mmHg |
21-22 mmHg |
>22 mmHg |
|
|
|
|
|
|
|
|
|
I-O cc/H |
175 cc/H |
125 cc/H |
75 cc/H |
0 cc/H |
-50 cc/H |
-75 cc/H |
-100 cc/H |
-125 cc/H |
Prescribing of medications
=Choice of agents Avoid -other nephrotoxins,
-ACE inhibitors,
-cyclooxygenase inhibitors,
-radiocontrast unless
absolute indication
and no alternative agent
=Drug dosing - Adjust doses and
frequency of
administration for
degree of renal impairment (CCr)
Management of the recovery phase of intrinsic and obstructive ARF
-careful monitoring of serum electrolytes,
volume status, urinary fluid and
electrolyte loss
-careful supplement of fluid and electrolyte when dehydration and electrolyte imbalance.
ACUTE COMPLICATION OF HEMODIALYSIS HYPOTENSION FACTOR 1 IN
ACUTE CONFUSION IN DIABETIC THE CAUSES OF CONFUSION OR
ACUTE EFFECTS OF EXERCISE POSTURE ON EXECUTIVE FUNCTION IN
Tags: acute renal, hus/ttp acute, acute, rapid, definition, renal, decrease, failure